All Medicines
Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Antineoplastic agents;Protein kinase inhibitors

Vanflyta

(quizartinib)

Uses, side effects, dosage information & price range

Daiichi Sankyo Europe GmbH

About this medicine

Vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by Vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (AML) that is FLT3-ITD positive.

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

IclusigComposition: ponatinibIncyte Biosciences Distribution B.V.
Price on RequestView Details →
ItovebiComposition: inavolisibRoche Registration GmbH
Price on RequestView Details →
LorviquaComposition: lorlatinibPfizer Europe MA EEIG
Price on RequestView Details →
StivargaComposition: regorafenibBayer Pharma AG
Price on RequestView Details →
Imatinib TevaComposition: imatinibTeva B.V.
Price on RequestView Details →

Key Information

Salt / Composition

quizartinib

Category

Antineoplastic agents;Protein kinase inhibitors

Manufacturer

Daiichi Sankyo Europe GmbH

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.